Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

Events & ConventionsAGC Pharma Chemicals named Champion in Small Molecule API at the European CDMO Leadership Awards 2025
29th October 2025

AGC Pharma Chemicals named Champion in Small Molecule API at the European CDMO Leadership Awards 2025

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
All of ArticlesCDMO ProcessesSetting New Standards in Micronization with Hosokawa Technology
22nd October 2025

Setting New Standards in Micronization with Hosokawa Technology

Pioneering Precision with Dual-System Technology: Reliable CDMO for Smal Molecule APIs and IntermediatesAGC leads the industry with its sophisticated dual-system mill technology, combining the power of opposed bed jet milling…
Events & ConventionsAGC Pharma Chemicals to Exhibit at CPHI Frankfurt 2025
14th October 2025

AGC Pharma Chemicals to Exhibit at CPHI Frankfurt 2025

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.